387 related articles for article (PubMed ID: 21918792)
21. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.
Sobel JD; Wiesenfeld HC; Martens M; Danna P; Hooton TM; Rompalo A; Sperling M; Livengood C; Horowitz B; Von Thron J; Edwards L; Panzer H; Chu TC
N Engl J Med; 2004 Aug; 351(9):876-83. PubMed ID: 15329425
[TBL] [Abstract][Full Text] [Related]
22. Colonization of voice prostheses by albicans and non-albicans Candida species.
Bauters TG; Moerman M; Vermeersch H; Nelis HJ
Laryngoscope; 2002 Apr; 112(4):708-12. PubMed ID: 12152601
[TBL] [Abstract][Full Text] [Related]
23. [Prerequisites for effective therapy of chronic recurrent vaginal candidiasis].
Kunzelmann V; Tietz HJ; Rossner D; Czaika V; Hopp M; Schmalreck A; Sterry W
Mycoses; 1996; 39 Suppl 1():65-72. PubMed ID: 8767274
[TBL] [Abstract][Full Text] [Related]
24. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.
Goswami D; Goswami R; Banerjee U; Dadhwal V; Miglani S; Lattif AA; Kochupillai N
J Infect; 2006 Feb; 52(2):111-7. PubMed ID: 15908007
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India.
Ahmad A; Khan AU
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):68-71. PubMed ID: 19261369
[TBL] [Abstract][Full Text] [Related]
26. [Study on Candida no-albicans species and its relation to recurrent vulvovaginal candidiasis].
Buitrón García R; Romero Cabello R; Cruz Talonia F; Bonifaz A; Zarama Marquez F
Ginecol Obstet Mex; 2002 Sep; 70():431-6. PubMed ID: 12448051
[TBL] [Abstract][Full Text] [Related]
27. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole.
Sobel JD; Kapernick PS; Zervos M; Reed BD; Hooton T; Soper D; Nyirjesy P; Heine MW; Willems J; Panzer H; Wittes H
Am J Obstet Gynecol; 2001 Aug; 185(2):363-9. PubMed ID: 11518893
[TBL] [Abstract][Full Text] [Related]
28. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
[TBL] [Abstract][Full Text] [Related]
29. Candida parapsilosis sensu stricto and the closely related species Candida orthopsilosis and Candida metapsilosis in vulvovaginal candidiasis.
Zhu Y; Shan Y; Fan S; Li J; Liu X
Mycopathologia; 2015 Feb; 179(1-2):111-8. PubMed ID: 25322705
[TBL] [Abstract][Full Text] [Related]
30. Non-albicans Candida Vulvovaginitis: Treatment Experience at a Tertiary Care Vaginitis Center.
Powell AM; Gracely E; Nyirjesy P
J Low Genit Tract Dis; 2016 Jan; 20(1):85-9. PubMed ID: 26083330
[TBL] [Abstract][Full Text] [Related]
31. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
32. [Combined single-day treatment in acute vulvovaginal candidosis].
Kovachev S; Nacheva A; Vacheva-Dobrevska R; Vasilev N
Akush Ginekol (Sofiia); 2009; 48(6):18-23. PubMed ID: 20225492
[TBL] [Abstract][Full Text] [Related]
33. Bioactive compounds with antifungal activity against pathogens isolated from pregnant woman: Gallesia integrifolia (garlic wood) is a promising treatment for vulvovaginal candidiasis.
de Souza ANV; Faria MGI; da Rocha CE; Philippsen GS; Silva GCC; da Silva GR; Inumaro RS; Gonçalves JE; Gazim ZC; Wietzikoski S; Lívero FADR; Seixas FAV; Wietzikoski Lovato EC
J Ethnopharmacol; 2022 Sep; 295():115403. PubMed ID: 35643209
[TBL] [Abstract][Full Text] [Related]
34. Vaginal Candida parapsilosis: pathogen or bystander?
Nyirjesy P; Alexander AB; Weitz MV
Infect Dis Obstet Gynecol; 2005 Mar; 13(1):37-41. PubMed ID: 16040326
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of resistance and sensitivity of 1 200 strains of vulvovaginal candidiasis in China to five common antifungal drugs].
Fan LY; Liu ZH; Bai XN; Zong X
Zhonghua Fu Chan Ke Za Zhi; 2022 Aug; 57(8):601-607. PubMed ID: 36008287
[No Abstract] [Full Text] [Related]
36. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
[TBL] [Abstract][Full Text] [Related]
37. [Study of acute vulvovaginitis in sexually active adult women, with special reference to candidosis, in patients of the Francisco J. Muñiz Infectious Diseases Hospital].
Buscemi L; Arechavala A; Negroni R
Rev Iberoam Micol; 2004 Dec; 21(4):177-81. PubMed ID: 15709796
[TBL] [Abstract][Full Text] [Related]
38. [Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents].
García Heredia M; García SD; Copolillo EF; Cora Eliseth M; Barata AD; Vay CA; de Torres RA; Tiraboschi N; Famiglietti AM
Rev Argent Microbiol; 2006; 38(1):9-12. PubMed ID: 16784126
[TBL] [Abstract][Full Text] [Related]
39. Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis.
Ray D; Goswami R; Dadhwal V; Goswami D; Banerjee U; Kochupillai N
J Infect; 2007 Oct; 55(4):374-7. PubMed ID: 17692922
[TBL] [Abstract][Full Text] [Related]
40. Vulvovaginal candidiasis from non-albicans species: retrospective study of recurrence rate after fluconazole therapy.
Ventolini G; Baggish MS; Walsh PM
J Reprod Med; 2006 Jun; 51(6):475-8. PubMed ID: 16846086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
